MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, PSNL made $69,648K in revenue. -$81,270K in net income. Net profit margin of -116.69%.

Income Overview

Revenue
$69,648K
Net Income
-$81,270K
Net Profit Margin
-116.69%
EPS
-$0.91
Unit: Thousand (K) dollars
Revenue Breakdown
    • Pharma Testing Services
    • Population Sequencing
    • Enterprise Sales
    • Others

Income Statement
2025-12-31
2024-12-31
Revenue
69,648 84,614
Cost of revenue
53,871 57,789
Research and development
50,264 48,905
Selling, general and administrative
53,570 46,187
Total costs and expenses
157,705 152,881
Loss from operations
-88,057 -68,267
Interest income
7,155 5,510
Interest expense
205 24
Other income (expense), net
-142 -18,485
Loss before income taxes
-81,249 -81,266
Provision for income taxes
21 18
Net loss
-81,270 -81,284
Basic EPS
-0.91 -1.37
Diluted EPS
-0.91 -1.37
Basic Average Shares
89,240,435 59,251,013
Diluted Average Shares
89,240,435 59,251,013
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$81,270K (0.02%↑ Y/Y)Loss before incometaxes-$81,249K (0.02%↑ Y/Y)Provision for income taxes$21K (16.67%↑ Y/Y)Interest income$7,155K (29.85%↑ Y/Y)Pharma TestingServices$48,661K Population Sequencing$11,766K (58.36%↑ Y/Y)Enterprise Sales$5,885K (-76.80%↓ Y/Y)Clinical Diagnostic$2,018K (165.88%↑ Y/Y)Other$1,318K (980.33%↑ Y/Y)Loss from operations-$88,057K (-28.99%↓ Y/Y)Revenue$69,648K (-17.69%↓ Y/Y)Interest expense$205K (754.17%↑ Y/Y)Other income(expense), net-$142K (99.23%↑ Y/Y)Total costs andexpenses$157,705K (3.16%↑ Y/Y)Cost of revenue$53,871K (-6.78%↓ Y/Y)Selling, general andadministrative$53,570K (15.99%↑ Y/Y)Research and development$50,264K (2.78%↑ Y/Y)

Personalis, Inc. (PSNL)

Personalis, Inc. (PSNL)